Portland, OR -- (SBWIRE) -- 10/06/2017 -- Acute lung injury is a life-threatening condition caused by severe acute hypoxemic respiratory failure. It is a key source of mortality and morbidity in critically ill patients without any evidence of hydrostatic pulmonary edema. Symptoms observed in acute lung injury include severe shortness of breath, low blood pressure, confusion, and extreme tiredness. This type of injury has a substantial impact on public health, with a high incidence across the world and it requires administration of a fast and goal-oriented therapy to suppress further lung damage.

The major factor that drives the Acute Lung Injury Market is the rise in prevalence of lung-related diseases, increase in geriatric population, growth in awareness about daily health diagnostics, and technological advancements. However, the high cost of therapies and low adoption rate of digital radiography and portable spirometers for diagnosing the condition impede the market growth. Furthermore, advancements in surgical techniques and the perioperative management, and development of new treatment strategies to improve outcomes are expected to provide numerous opportunities for market expansion in the near future.

Exclusive Offer !!! Get Flat 20% discount on this report

Acute Lung Injury Market Report Key Benefits:

-The study provides an in-depth analysis of the global acute lung injury market with current trends and future estimations from 2016 to 2023 to elucidate the imminent investment pockets.

-Comprehensive analysis of factors that drive and restrict the market growth is provided.

-Identification of factors instrumental in changing the market scenario, rise in opportunities, and identification of key companies that can influence this market on a global and regional scale are provided.

-Key players are profiled and their strategies are analyzed thoroughly to understand the competitive outlook of the market.

To request a sample copy of this report, Click Here :https://www.alliedmarketresearch.com/request-toc-and-sample/4392

Acute Lung Injury Market Key Segments:

By Therapy

-Pharmacotherapy
-Mechanical Ventilation
-Adjunctive Procedures
-Fluid Management
-Others

By End User

-Hospitals
-Clinics
-Others

By Region

-North America
-Europe
-Asia-Pacific
-LAMEA

The key players operating in this market include Altor BioScience Corporation, FirstString Research, Inc., GlaxoSmithKline Plc, Forschung und Entwicklung GmbH, Commence Bio, Inc., CompleGen, Inc., Histocell S.L., Stemedica Cell Technologies, Inc., Windtree Therapeutics, Inc., and S-Evans Biosciences, Inc.